System for predicting therapy resistance and its molecular mechanisms in rectal cancer before treatment
US12057234B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | Oct 31, 2023 |
| Grant date | Aug 6, 2024 |
| Priority date | — |
| Expiry date | Oct 31, 2043 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A90/10
- WIPO fieldComputer technology
- WIPO sectorElectrical engineering
Abstract
A system for predicting therapy resistance and its molecular mechanisms in rectal cancer before treatment is provided. The system includes a feature extraction device, a collection device, a signature construction device and a prediction device. The system can predict responses to neoadjuvant therapy in patients before treatment, analyze patients who are resistant to rectal cancer therapy and their underlying molecular mechanism, thereby enabling personalized therapy for patients who are resistant to rectal cancer therapy. The system has important clinical significance in improving the overall survival of rectal cancer patients.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.